Background The prevalence of pre-diabetes mellitus and its consequences in patients with heart failure and reduced ejection fraction are not known. We investigated these in the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) trial
Diabetes and heart failure (HF) are both global epidemics with tremendous costs on society with incr...
BackgroundDiabetes is prevalent worldwide including hospitalized patients with heart failure with re...
Chronic hyperglycaemia, assessed by elevated glycated haemoglobin (A1C), is a known risk factor for ...
BACKGROUND: The prevalence of pre-diabetes mellitus and its consequences in patients with heart fai...
Background—The prevalence of pre–diabetes mellitus and its consequences in patients with heart failu...
The prevalence of pre–diabetes mellitus and its consequences in patients with heart failure and redu...
BACKGROUND: The prevalence of pre-diabetes mellitus and its consequences in patients with heart fail...
BACKGROUND: The prevalence of pre-diabetes mellitus and its consequences in patients with heart fail...
Aim: The frequency and implications of pre-diabetes Mellitus in individuals having heart failure in ...
Background—The prevalence of pre–diabetes mellitus and its consequences in patients with heart failu...
Aim: There is an association between heart failure with preserved ejection fraction (HFpEF) and insu...
Aims To determine whether the risk of adverse cardiovascular (CV) outcomes associated with diabetes ...
Purpose The prevalence and consequences of prediabetic dysglycemia and undiagnosed diabetes is unkno...
BackgroundDiabetes is prevalent worldwide including hospitalized patients with heart failure with re...
Many episodes of worsening of heart failure (HF) are treated by increasing oral therapy or temporary...
Diabetes and heart failure (HF) are both global epidemics with tremendous costs on society with incr...
BackgroundDiabetes is prevalent worldwide including hospitalized patients with heart failure with re...
Chronic hyperglycaemia, assessed by elevated glycated haemoglobin (A1C), is a known risk factor for ...
BACKGROUND: The prevalence of pre-diabetes mellitus and its consequences in patients with heart fai...
Background—The prevalence of pre–diabetes mellitus and its consequences in patients with heart failu...
The prevalence of pre–diabetes mellitus and its consequences in patients with heart failure and redu...
BACKGROUND: The prevalence of pre-diabetes mellitus and its consequences in patients with heart fail...
BACKGROUND: The prevalence of pre-diabetes mellitus and its consequences in patients with heart fail...
Aim: The frequency and implications of pre-diabetes Mellitus in individuals having heart failure in ...
Background—The prevalence of pre–diabetes mellitus and its consequences in patients with heart failu...
Aim: There is an association between heart failure with preserved ejection fraction (HFpEF) and insu...
Aims To determine whether the risk of adverse cardiovascular (CV) outcomes associated with diabetes ...
Purpose The prevalence and consequences of prediabetic dysglycemia and undiagnosed diabetes is unkno...
BackgroundDiabetes is prevalent worldwide including hospitalized patients with heart failure with re...
Many episodes of worsening of heart failure (HF) are treated by increasing oral therapy or temporary...
Diabetes and heart failure (HF) are both global epidemics with tremendous costs on society with incr...
BackgroundDiabetes is prevalent worldwide including hospitalized patients with heart failure with re...
Chronic hyperglycaemia, assessed by elevated glycated haemoglobin (A1C), is a known risk factor for ...